Pharmaceutical companies have a strategy to block out competition to their prescription drugs. According to a new study, about 7% of all pharma mergers and acquisitions from 1989 to 2011 are so ...

highly differentiated pharmaceutical company. I look forward to all that we will accomplish as we grow globally and embrace new opportunities, driven by our purpose." The acquisition follows a ...

citing the specialty pharma company’s growth prospects. ANIP, a maker of branded and generic pharmaceuticals, is positioned to generate high single-digit top-line growth and low double-digit ...